Daniele Santini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. a “real life” retrospective analysis of progression-free (PFS) and overall survival (OS) according to duration of androgen deprivation therapy	JOURNAL OF CLINICAL ONCOLOGY	2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies	EXPERT REVIEW OF VACCINES	2016
H2020 and beyond: skip discrepancy between theory and practice of personalized medicine. A position paper by the italian society of personalized medicine	CURRENT PHARMACEUTICAL BIOTECHNOLOGY	2016
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients. A multicenter Italian experience	THE BREAST	2016
"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome	ONCOTARGET	2016
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model	ANNALS OF ONCOLOGY	2016
Integrin a5 is an independent prognosis factor and a potential therapeutic target for breast cancer bone metastasis	ANNALS OF ONCOLOGY	2016
M1-polarized macrophages as predictor of poor response to trabectedin treatment in myxoid liposarcoma	JOURNAL OF CLINICAL ONCOLOGY	2016
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma	ANNALS OF ONCOLOGY	2016
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma	JOURNAL OF CLINICAL ONCOLOGY	2016
Biological effects of cabozantinib on bone microenvironment	JOURNAL OF CLINICAL ONCOLOGY	2016
Bone-Targeted Agents	Bone Metastases from Prostate Cancer	2016
Bone-Targeted Agents	Bone Metastases from Prostate Cancer	2016
RE: Regorafenib Also Can Cause Osteonecrosis of the Jaw	JOURNAL OF THE NATIONAL CANCER INSTITUTE	2016
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis	ONCOTARGET	2016
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib	ONCOTARGET	2016
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma	CANCER CHEMOTHERAPY AND PHARMACOLOGY	2016
Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study	ONCOTARGET	2016
Overcoming dynamic molecular heterogeneity in metastatic colorectal cancer: Multikinase inhibition with regorafenib and the case of rechallenge with anti-EGFR"	CANCER TREATMENT REVIEWS	2016
Adjuvant bisphosphonates in early breast cancer. Consensus guidance for clinical practice from a European Panel	ANNALS OF ONCOLOGY	2016